Breaking News Instant updates and real-time market news.

ALLO

Allogene Therapeutics

$19.07 /

+0.82 (+4.49%)

07:29
12/03/21
12/03
07:29
12/03/21
07:29

Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord

Canaccord analyst John Newman believes Allogene's clinical hold could be lifted shortly, based on historical median duration of 3.3 months, with 70% of all programs coming off clinical hold. The analyst also said its clinical hold was mild compared to other CART companies as its clinical hold does not involve any patient deaths. He also believes its ALLO-501A will receive FDA approval and be preferred due to its off-the-shelf, immediately available formulation vs customized autologous products. Newman reiterated his Buy rating and $55 price target on Allogene shares.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Ulta Beauty price target lowered to $450 from $485 at Raymond James » 06:56
01/26/22
01/26
06:56
01/26/22
06:56
ULTA

Ulta Beauty

$352.73 /

-12.41 (-3.40%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$352.73 /

-12.41 (-3.40%)

ULTA Ulta Beauty
$352.73 /

-12.41 (-3.40%)

01/25/22 Piper Sandler
Ulta Beauty transferred with Overweight at Piper Sandler
01/14/22 JPMorgan
Ulta Beauty added to Analyst Focus List at JPMorgan
01/04/22 Oppenheimer
Estee Lauder price target raised to $410 from $355 at Oppenheimer
12/30/21 DA Davidson
Ulta Beauty price target raised to $500 from $445 at DA Davidson
ULTA Ulta Beauty
$352.73 /

-12.41 (-3.40%)

ULTA Ulta Beauty
$352.73 /

-12.41 (-3.40%)

ULTA Ulta Beauty
$352.73 /

-12.41 (-3.40%)

ULTA Ulta Beauty
$352.73 /

-12.41 (-3.40%)

Earnings
Myovant Sciences reports Q3 EPS (68c), consensus (60c) » 06:56
01/26/22
01/26
06:56
01/26/22
06:56
MYOV

Myovant Sciences

$13.10 /

-0.095 (-0.72%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
$13.10 /

-0.095 (-0.72%)

MYOV Myovant Sciences
$13.10 /

-0.095 (-0.72%)

09/09/21 SVB Leerink
SVB Leerink starts Myovant at Market Perform
09/09/21 SVB Leerink
Myovant Sciences initiated with a Market Perform at SVB Leerink
08/19/21 Goldman Sachs
Myovant Sciences assumed with a Neutral at Goldman Sachs
05/13/21 Citi
Myovant Sciences price target lowered to $24 from $30 at Citi
MYOV Myovant Sciences
$13.10 /

-0.095 (-0.72%)

MYOV Myovant Sciences
$13.10 /

-0.095 (-0.72%)

Earnings
Oshkosh reports Q1 adjusted EPS $1.13, consensus 49c » 06:56
01/26/22
01/26
06:56
01/26/22
06:56
OSK

Oshkosh

$117.02 /

+0.33 (+0.28%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSK Oshkosh
$117.02 /

+0.33 (+0.28%)

OSK Oshkosh
$117.02 /

+0.33 (+0.28%)

01/07/22 BofA
Oshkosh downgraded to Neutral from Buy at BofA
12/22/21 Baird
Oshkosh named a top idea for 2022 at Baird
12/20/21 Deutsche Bank
Oshkosh price target lowered to $127 from $128 at Deutsche Bank
12/17/21 DA Davidson
Oshkosh initiated with a Neutral at DA Davidson
OSK Oshkosh
$117.02 /

+0.33 (+0.28%)

OSK Oshkosh
$117.02 /

+0.33 (+0.28%)

OSK Oshkosh
$117.02 /

+0.33 (+0.28%)

Recommendations
3M price target raised to $184 from $175 at Wells Fargo » 06:55
01/26/22
01/26
06:55
01/26/22
06:55
MMM

3M

$173.77 /

+0.965 (+0.56%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMM 3M
$173.77 /

+0.965 (+0.56%)

MMM 3M
$173.77 /

+0.965 (+0.56%)

01/11/22 Bernstein
Bernstein initiates 3M with a Market Perform, $175 price target
01/10/22 Bernstein
3M initiated with a Market Perform at Bernstein
01/04/22 RBC Capital
3M downgraded to Underperform from Sector Perform at RBC Capital
01/04/22 Barclays
3M price target lowered to $177 from $182 at Barclays
MMM 3M
$173.77 /

+0.965 (+0.56%)

MMM 3M
$173.77 /

+0.965 (+0.56%)

MMM 3M
$173.77 /

+0.965 (+0.56%)

MMM 3M
$173.77 /

+0.965 (+0.56%)

Recommendations
Johnson & Johnson price target raised to $185 from $178 at Raymond James » 06:54
01/26/22
01/26
06:54
01/26/22
06:54
JNJ

Johnson & Johnson

$167.66 /

+4.63 (+2.84%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$167.66 /

+4.63 (+2.84%)

JNJ Johnson & Johnson
$167.66 /

+4.63 (+2.84%)

01/25/22 Citi
Johnson & Johnson quarter reflected 'resilience,' says Citi
12/29/21 Credit Suisse
Credit Suisse reiterates Outperform on J&J as trends point to pharma upside
12/17/21
Fly Intel: Top five analyst initiations
12/17/21 Goldman Sachs
Goldman starts Johnson & Johnson at Neutral amid disruption risk
JNJ Johnson & Johnson
$167.66 /

+4.63 (+2.84%)

JNJ Johnson & Johnson
$167.66 /

+4.63 (+2.84%)

JNJ Johnson & Johnson
$167.66 /

+4.63 (+2.84%)

JNJ Johnson & Johnson
$167.66 /

+4.63 (+2.84%)

Recommendations
Lockheed Martin price target raised to $400 from $379 at Wells Fargo » 06:54
01/26/22
01/26
06:54
01/26/22
06:54
LMT

Lockheed Martin

$387.07 /

+13.61 (+3.64%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$387.07 /

+13.61 (+3.64%)

LMT Lockheed Martin
$387.07 /

+13.61 (+3.64%)

06:14 Today Bernstein
Lockheed Martin price target raised to $401 from $387 at Bernstein
01/10/22 Wells Fargo
Lockheed Martin price target raised to $379 from $340 at Wells Fargo
12/31/21 Morgan Stanley
TransDigm, Northrop Grumman named top picks for 2022 at Morgan Stanley
11/01/21 BofA
BofA cuts Lockheed Martin to Neutral on slowing growth, 'inconsistent' strategy
LMT Lockheed Martin
$387.07 /

+13.61 (+3.64%)

LMT Lockheed Martin
$387.07 /

+13.61 (+3.64%)

LMT Lockheed Martin
$387.07 /

+13.61 (+3.64%)

LMT Lockheed Martin
$387.07 /

+13.61 (+3.64%)

Upgrade
Chipotle upgraded to Buy from Hold at Gordon Haskett » 06:53
01/26/22
01/26
06:53
01/26/22
06:53
CMG

Chipotle

$1,368.87 /

-46.185 (-3.26%)

Gordon Haskett analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMG Chipotle
$1,368.87 /

-46.185 (-3.26%)

CMG Chipotle
$1,368.87 /

-46.185 (-3.26%)

06:51 Today Gordon Haskett
Correction: Chipotle upgraded to Buy from Hold at Gordon Haskett
06:24 Today Gordon Haskett
Chipotle upgraded to Buy from Accumulate at Gordon Haskett
01/24/22 UBS
Chipotle pullback provides attractive entry point, says UBS
01/21/22 KeyBanc
Chipotle price target lowered to $1,850 from $2,100 at KeyBanc
CMG Chipotle
$1,368.87 /

-46.185 (-3.26%)

CMG Chipotle
$1,368.87 /

-46.185 (-3.26%)

CMG Chipotle
$1,368.87 /

-46.185 (-3.26%)

Recommendations
American Express price target raised to $215 from $200 at Wells Fargo » 06:52
01/26/22
01/26
06:52
01/26/22
06:52
AXP

American Express

$173.11 /

+14.075 (+8.85%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXP American Express
$173.11 /

+14.075 (+8.85%)

AXP American Express
$173.11 /

+14.075 (+8.85%)

06:32 Today Credit Suisse
American Express price target raised to $170 from $163 at Credit Suisse
06:32 Today Barclays
American Express price target raised to $190 from $182 at Barclays
06:12 Today BofA
American Express upgraded to Buy from Neutral at BofA
06:05 Today BofA
American Express upgraded to Buy from Neutral at BofA
AXP American Express
$173.11 /

+14.075 (+8.85%)

AXP American Express
$173.11 /

+14.075 (+8.85%)

AXP American Express
$173.11 /

+14.075 (+8.85%)

AXP American Express
$173.11 /

+14.075 (+8.85%)

Hot Stocks
Tyme Technologies discontinues Phase 2/3 trial in metastatic pancreatic cancer » 06:52
01/26/22
01/26
06:52
01/26/22
06:52
TYME

Tyme Technologies

/

+

Tyme Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TYME Tyme Technologies
/

+

TYME Tyme Technologies
/

+

Hot Stocks
Brookfield Renewable Partners acquires Urban Grid for $650M » 06:51
01/26/22
01/26
06:51
01/26/22
06:51
BEP

Brookfield Renewable Partners

$31.66 /

-1 (-3.06%)

Brookfield Renewable,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BEP Brookfield Renewable Partners
$31.66 /

-1 (-3.06%)

BEP Brookfield Renewable Partners
$31.66 /

-1 (-3.06%)

01/20/22 JPMorgan
Brookfield Renewable Partners price target lowered to $39 from $46 at JPMorgan
01/18/22 National Bank
Brookfield Renewable Partners upgraded to Outperform at National Bank
01/16/22 BMO Capital
Brookfield Renewable Partners upgraded to Outperform at BMO Capital
01/11/22 CIBC
Brookfield Renewable Partners upgraded with $40 target at CIBC
BEP Brookfield Renewable Partners
$31.66 /

-1 (-3.06%)

BEP Brookfield Renewable Partners
$31.66 /

-1 (-3.06%)

Downgrade
Usiminas downgraded to Hold from Buy at HSBC » 06:50
01/26/22
01/26
06:50
01/26/22
06:50
USNZY

Usiminas

/

+

HSBC analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USNZY Usiminas
/

+

12/10/21 Goldman Sachs
Usiminas initiated with a Buy at Goldman Sachs
11/12/21 Citi
Usiminas upgraded to Buy from Neutral at Citi
10/19/21 Grupo Santander
Usiminas upgraded to Buy from Hold at Grupo Santander
08/16/21 Itau BBA
Usiminas downgraded to Market Perform from Outperform at Itau BBA
Recommendations
Yeti price target lowered to $100 from $115 at Credit Suisse » 06:50
01/26/22
01/26
06:50
01/26/22
06:50
YETI

Yeti

$67.27 /

-1.69 (-2.45%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$67.27 /

-1.69 (-2.45%)

YETI Yeti
$67.27 /

-1.69 (-2.45%)

11/12/21 UBS
Yeti price target raised to $99 from $92 at UBS
11/12/21 Cowen
Yeti price target lowered to $114 from $118 at Cowen
11/12/21 Baird
Yeti weakness a buying opportunity, says Baird
11/12/21 BTIG
Yeti price target raised to $125 from $116 at BTIG
YETI Yeti
$67.27 /

-1.69 (-2.45%)

YETI Yeti
$67.27 /

-1.69 (-2.45%)

YETI Yeti
$67.27 /

-1.69 (-2.45%)

Earnings
Universal Stainless & Alloy reports Q4 EPS (18c), one estimate (13c) » 06:48
01/26/22
01/26
06:48
01/26/22
06:48
USAP

Universal Stainless & Alloy

$8.30 /

+0.05 (+0.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USAP Universal Stainless & Alloy
$8.30 /

+0.05 (+0.61%)

USAP Universal Stainless & Alloy
$8.30 /

+0.05 (+0.61%)

Earnings
RPC, Inc. reports Q4 EPS (3c), consensus 3c » 06:48
01/26/22
01/26
06:48
01/26/22
06:48
RES

RPC, Inc.

$6.02 /

+0.42 (+7.50%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RES RPC, Inc.
$6.02 /

+0.42 (+7.50%)

09/13/21 Citi
Citi positive on oilfield services, upgrades Liberty to Buy, RPC to Neutral
09/13/21 Citi
RPC, Inc. upgraded to Neutral from Sell at Citi
02/17/21 Citi
RPC, Inc. price target raised to $3.50 from $3 at Citi
RES RPC, Inc.
$6.02 /

+0.42 (+7.50%)

Recommendations
Cambridge Bancorp price target raised to $100 from $96 at Raymond James » 06:48
01/26/22
01/26
06:48
01/26/22
06:48
CATC

Cambridge Bancorp

$92.01 /

-0.95 (-1.02%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CATC Cambridge Bancorp
$92.01 /

-0.95 (-1.02%)

CATC Cambridge Bancorp
$92.01 /

-0.95 (-1.02%)

01/09/22 Keefe Bruyette
Cambridge Bancorp transferred with Outperform at Keefe Bruyette
10/13/21 Janney Montgomery Scott
Cambridge Bancorp initiated with a Buy at Janney Montgomery Scott
07/18/21 Keefe Bruyette
Cambridge Bancorp assumed with an Outperform at Keefe Bruyette
01/26/21 Raymond James
Cambridge Bancorp price target raised to $85 from $70 at Raymond James
CATC Cambridge Bancorp
$92.01 /

-0.95 (-1.02%)

Recommendations
Traeger price target lowered to $14 from $28 at Credit Suisse » 06:48
01/26/22
01/26
06:48
01/26/22
06:48
COOK

Traeger

$9.61 /

-0.395 (-3.95%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COOK Traeger
$9.61 /

-0.395 (-3.95%)

COOK Traeger
$9.61 /

-0.395 (-3.95%)

01/18/22 Baird
Traeger, Freshpet, Driven Brands named top retail ideas at Baird
11/16/21 Credit Suisse
Traeger price target lowered to $28 from $33 at Credit Suisse
11/16/21 Baird
Traeger price target lowered to $25 from $32 at Baird
08/30/21
Fly Intel: Top five analyst initiations
COOK Traeger
$9.61 /

-0.395 (-3.95%)

  • 29
    Jul
COOK Traeger
$9.61 /

-0.395 (-3.95%)

COOK Traeger
$9.61 /

-0.395 (-3.95%)

Upgrade
UiPath upgraded to Outperform yesterday at Macquarie » 06:48
01/26/22
01/26
06:48
01/26/22
06:48
PATH

UiPath

$35.27 /

-1.265 (-3.46%)

As previously reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PATH UiPath
$35.27 /

-1.265 (-3.46%)

PATH UiPath
$35.27 /

-1.265 (-3.46%)

01/25/22 Macquarie
UiPath upgraded to Outperform from Neutral at Macquarie
01/20/22 Oppenheimer
Oppenheimer upgrades UiPath to Outperform with $56 price target
01/20/22 Oppenheimer
UiPath upgraded to Outperform from Perform at Oppenheimer
01/12/22 Barclays
UiPath price target lowered to $57 from $61 at Barclays
PATH UiPath
$35.27 /

-1.265 (-3.46%)

  • 29
    Jun
  • 18
    Jun
  • 21
    Apr
PATH UiPath
$35.27 /

-1.265 (-3.46%)

PATH UiPath
$35.27 /

-1.265 (-3.46%)

Downgrade
Clicks Group downgraded to Hold from Buy at HSBC » 06:47
01/26/22
01/26
06:47
01/26/22
06:47
CLCGY

Clicks Group

$42.07 /

+0.87 (+2.11%)

HSBC analyst Thapelo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Equinor downgraded to Neutral from Buy at BofA » 06:47
01/26/22
01/26
06:47
01/26/22
06:47
EQNR

Equinor

$28.97 /

+0.81 (+2.88%)

BofA analyst Mehdi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQNR Equinor
$28.97 /

+0.81 (+2.88%)

EQNR Equinor
$28.97 /

+0.81 (+2.88%)

06:19 Today BofA
Equinor downgraded to Neutral from Buy at BofA
01/14/22 JPMorgan
Equinor price target raised to NOK 255 from NOK 235 at JPMorgan
01/14/22 Berenberg
Equinor downgraded to Hold from Buy at Berenberg
01/12/22 Morgan Stanley
Equinor price target raised to NOK 217 from NOK 202 at Morgan Stanley
Recommendations
SmartFinancial price target raised to $33 from $30 at Raymond James » 06:46
01/26/22
01/26
06:46
01/26/22
06:46
SMBK

SmartFinancial

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMBK SmartFinancial
/

+

SMBK SmartFinancial
/

+

07/21/21 Raymond James
SmartFinancial price target raised to $30 from $27 at Raymond James
04/22/21 Raymond James
SmartFinancial upgraded to Strong Buy from Outperform at Raymond James
SMBK SmartFinancial
/

+

Initiation
Ballard Power initiated with a Neutral at Susquehanna » 06:46
01/26/22
01/26
06:46
01/26/22
06:46
BLDP

Ballard Power

$9.49 /

-0.31 (-3.16%)

Susquehanna analyst Biju…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLDP Ballard Power
$9.49 /

-0.31 (-3.16%)

BLDP Ballard Power
$9.49 /

-0.31 (-3.16%)

06:46 Today Susquehanna
Correction: Ballard Power initiated with a Neutral at Susquehanna
01/24/22 Truist
Ballard Power price target lowered to $13 from $18 at Truist
01/05/22 KeyBanc
Ballard Power initiated with a Sector Weight at KeyBanc
11/20/21 Citi
Citi initiates pair trade of Overweight Plug Power, Underweight Ballard Power
BLDP Ballard Power
$9.49 /

-0.31 (-3.16%)

  • 10
    Mar
  • 10
    Feb
BLDP Ballard Power
$9.49 /

-0.31 (-3.16%)

BLDP Ballard Power
$9.49 /

-0.31 (-3.16%)

Recommendations
PepsiCo price target raised to $166 from $157 at Credit Suisse » 06:46
01/26/22
01/26
06:46
01/26/22
06:46
PEP

PepsiCo

$171.32 /

-2.08 (-1.20%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEP PepsiCo
$171.32 /

-2.08 (-1.20%)

PEP PepsiCo
$171.32 /

-2.08 (-1.20%)

01/04/22 Argus
PepsiCo price target raised to $195 from $180 at Argus
10/07/21 Barclays
PepsiCo price target raised to $168 from $165 at Barclays
10/06/21 UBS
PepsiCo price target raised to $172 from $170 at UBS
10/06/21 Argus
PepsiCo reported 'strong quarter', says Argus
PEP PepsiCo
$171.32 /

-2.08 (-1.20%)

PEP PepsiCo
$171.32 /

-2.08 (-1.20%)

PEP PepsiCo
$171.32 /

-2.08 (-1.20%)

PEP PepsiCo
$171.32 /

-2.08 (-1.20%)

Recommendations
Microsoft growth prospects 'greater than many realize,' says Mizuho » 06:45
01/26/22
01/26
06:45
01/26/22
06:45
MSFT

Microsoft

$289.02 /

-7.72 (-2.60%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$289.02 /

-7.72 (-2.60%)

MSFT Microsoft
$289.02 /

-7.72 (-2.60%)

06:42 Today BMO Capital
Microsoft price target lowered to $355 from $360 at BMO Capital
06:38 Today Credit Suisse
Credit Suisse remains bullish on Microsoft following quarterly results
06:30 Today Deutsche Bank
Microsoft thesis 'remains firmly intact' after Q2, says Deutsche Bank
06:18 Today Citi
Microsoft price target raised to $386 from $376 at Citi
MSFT Microsoft
$289.02 /

-7.72 (-2.60%)

MSFT Microsoft
$289.02 /

-7.72 (-2.60%)

MSFT Microsoft
$289.02 /

-7.72 (-2.60%)

MSFT Microsoft
$289.02 /

-7.72 (-2.60%)

Earnings
First Citizens reports Q4 EPS $12.09, consensus $5.95 » 06:44
01/26/22
01/26
06:44
01/26/22
06:44
FCNCA

First Citizens

$810.00 /

-10.86 (-1.32%)

Reports Q4 NII $123.3M, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FCNCA First Citizens
$810.00 /

-10.86 (-1.32%)

FCNCA First Citizens
$810.00 /

-10.86 (-1.32%)

10/01/21 DA Davidson
First Citizens price target lowered to $1,000 from $1,020 at DA Davidson
08/27/21 Janney Montgomery Scott
Janney starts First Citizen at Buy ahead of CIT merger, sees 25% upside
08/27/21 Janney Montgomery Scott
First Citizens initiated with a Buy at Janney Montgomery Scott
04/19/21 Keefe Bruyette
Keefe Bruyette upgrades CIT Group on merger with First Citizens
FCNCA First Citizens
$810.00 /

-10.86 (-1.32%)

FCNCA First Citizens
$810.00 /

-10.86 (-1.32%)

Recommendations
Celsius Holdings price target lowered to $50 from $103 at Credit Suisse » 06:44
01/26/22
01/26
06:44
01/26/22
06:44
CELH

Celsius Holdings

$44.28 /

-2.68 (-5.71%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CELH Celsius Holdings
$44.28 /

-2.68 (-5.71%)

CELH Celsius Holdings
$44.28 /

-2.68 (-5.71%)

12/02/21 UBS
Celsius Holdings initiated with a Buy at UBS
11/15/21 Stifel
Celsius Holdings initiated with Buy, $95 target at Stifel
11/15/21 Stifel
Celsius Holdings initiated with a Buy at Stifel
11/12/21
Fly Intel: Top five analyst downgrades
CELH Celsius Holdings
$44.28 /

-2.68 (-5.71%)

  • 10
    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.